Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel
NYSE:ACH

Accendra Health Q2 2026 Earnings Results & Report

$0.28 -0.03 (-9.97%)
As of 01:23 PM Eastern

Accendra Health missed analyst earnings expectations in its Q2 2026 results, released August 10, 2026. The company reported EPS of -$0.19 versus the -$0.13 consensus estimate, while revenue was $613.23 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens

Accendra Health EPS Results

Actual EPS
-$0.19
Consensus EPS
-$0.13
Beat/Miss
Missed by -$0.06
One Year Ago EPS
N/A

Accendra Health Revenue Results

Actual Revenue
$613.23 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Accendra Health Q2 2026 Earnings FAQ

Accendra Health (NYSE:ACH) reported earnings of -$0.19 per share for Q2 2026, missing the consensus estimate of -$0.13. The report was announced on Monday, August 10, 2026.

Accendra Health reported revenue of $613.23 million for Q2 2026.

Accendra Health Earnings Headlines

Accendra Health Inc ACH
October 11 at 7:22 AM  |  morningstar.comM
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
October 9, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20261009281367/en/accendra-health-receives-continued-listing-standard-notice-from-nyse-intends-to-cure-deficiency-and-return-to-compliance-with-nyse-listing-standard/
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
October 14 at 1:00 AM  |  Profits Run (Ad)
Accendra Health (NYSE:ACH) Stock Rating Cut to Strong Sell at Zacks Research
October 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31096076
Accendra Health Names Kenneth Gardner-Smith As New CEO
September 17, 2026  |  rttnews.comhttps://www.rttnews.com/3691823/accendra-health-names-kenneth-gardner-smith-as-new-ceo.aspx
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
September 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/accendra-health-names-kenneth-gardner-103000681.html
See More Accendra Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Accendra Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Accendra Health and other key companies, straight to your email.

About Accendra Health

Accendra Health (NYSE:ACH) Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

View Accendra Health Profile
Earnings Tools